MediBeacon Inc. is an innovative medical technology company founded in 2012, focused on revolutionizing the assessment of kidney function through its proprietary TGFR™ System. With a strong foundation built on decades of research and development, MediBeacon aims to provide a first-in-kind solution for clinicians at the point of care, enhancing patient care in prestigious medical centers across the U.S. The company is driven by a highly motivated team with experience in both entrepreneurial and large medical device environments, and is currently preparing for the commercialization of its groundbreaking product, which is set to launch in early access programs in 2026. MediBeacon's commitment to excellence is reflected in its collaborative work culture and the opportunity for employees to grow alongside the company as it transitions into a new phase of operations.